Profile data is unavailable for this security.
About the company
Zimmer Biomet Holdings, Inc. is a global medical technology company. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. It also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.
- Revenue in USD (TTM)8.23bn
- Net income in USD704.60m
- Incorporated2001
- Employees17.00k
- LocationZimmer Biomet Holdings Inc345 E Main StWARSAW 46580-2746United StatesUSA
- Phone+1 (574) 267-6131
- Fax+1 (302) 636-5454
- Websitehttps://www.zimmerbiomet.com/en
More ▼
Mergers & acquisitions
| Acquired company | ZBH:NYQ since announced | Transaction value |
|---|---|---|
| Monogram Technologies Inc | 4.46% | 606.16m |
Data delayed at least 15 minutes, as of Mar 03 2026 21:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revvity Inc | 2.86bn | 239.88m | 10.69bn | 11.00k | 46.14 | 1.48 | 16.56 | 3.74 | 2.07 | 2.08 | 24.49 | 64.57 | 0.2326 | 3.46 | 4.15 | 259,641.00 | 1.95 | 3.23 | 2.13 | 3.58 | 54.77 | 58.48 | 8.40 | 13.58 | 1.40 | 5.01 | 0.3075 | 8.08 | 3.67 | -5.47 | -15.26 | -19.91 | -1.05 | 0.00 |
| Guardant Health Inc | 982.02m | -416.28m | 12.10bn | 2.49k | -- | -- | -- | 12.32 | -3.31 | -3.31 | 7.83 | -0.7602 | 0.5613 | 4.45 | 7.92 | 394,385.90 | -23.79 | -25.70 | -28.02 | -28.93 | 64.46 | 63.20 | -42.39 | -76.30 | 4.56 | -- | 1.07 | -- | 32.88 | 27.92 | 4.61 | -- | -2.23 | -- |
| Solventum Corp | 8.33bn | 1.56bn | 12.66bn | 20.00k | 8.23 | 2.51 | 6.19 | 1.52 | 8.87 | 8.87 | 47.48 | 29.10 | 0.5791 | 3.81 | 8.01 | 416,250.00 | 10.82 | -- | 13.58 | -- | 53.57 | 56.92 | 18.69 | 15.05 | 0.8906 | 2.05 | 0.4993 | -- | 0.8602 | 2.72 | 224.84 | 6.46 | 6.94 | -- |
| Globus Medical Inc | 2.94bn | 537.87m | 12.69bn | 6.00k | 23.84 | 2.77 | 15.55 | 4.32 | 3.93 | 3.93 | 21.44 | 33.86 | 0.5569 | 1.35 | 4.75 | 489,821.80 | 10.19 | 6.18 | 11.69 | 6.89 | 67.41 | 66.20 | 18.30 | 12.25 | 2.74 | -- | 0.0002 | 0.00 | 16.65 | 30.08 | 422.28 | 39.37 | 22.34 | -- |
| Penumbra Inc | 1.40bn | 177.69m | 13.43bn | 4.70k | 75.68 | 9.41 | 68.83 | 9.57 | 4.52 | 4.52 | 35.73 | 36.39 | 0.8356 | 1.10 | 7.85 | 298,652.10 | 10.58 | 4.03 | 11.77 | 4.49 | 67.14 | 64.57 | 12.66 | 5.39 | 4.29 | -- | 0.0159 | 0.00 | 17.50 | 20.16 | 1,168.11 | -- | 20.82 | -- |
| Align Technology Inc | 4.03bn | 410.35m | 13.47bn | 20.29k | 33.40 | 3.33 | 20.80 | 3.34 | 5.66 | 5.66 | 55.59 | 56.74 | 0.6483 | 5.33 | 3.85 | 198,864.70 | 6.59 | 8.11 | 9.67 | 11.97 | 68.27 | 70.62 | 10.17 | 12.31 | 1.24 | -- | 0.00 | 0.00 | 0.899 | 10.30 | -2.61 | -25.40 | -7.94 | -- |
| Cooper Companies Inc | 4.09bn | 374.90m | 16.37bn | 15.00k | 44.79 | 2.00 | 21.77 | 4.00 | 1.87 | 1.87 | 20.46 | 42.06 | 0.3312 | 1.71 | 5.29 | 272,826.70 | 3.03 | 8.04 | 3.32 | 8.86 | 65.54 | 66.01 | 9.16 | 24.66 | 1.13 | 6.32 | 0.2332 | 0.2049 | 5.06 | 10.98 | -4.44 | 9.48 | 3.15 | -- |
| Hologic Inc | 4.13bn | 543.80m | 16.84bn | 7.07k | 31.31 | 3.21 | 20.07 | 4.08 | 2.41 | 2.41 | 18.28 | 23.51 | 0.4608 | 2.57 | 6.79 | 583,663.40 | 6.07 | 11.22 | 6.82 | 12.85 | 56.51 | 60.20 | 13.18 | 21.99 | 3.32 | 15.76 | 0.3246 | 0.00 | 1.74 | 1.66 | -28.35 | -12.69 | -0.5168 | -- |
| Insulet Corp | 2.71bn | 247.10m | 17.28bn | 5.40k | 70.12 | 11.40 | 51.18 | 6.38 | 3.50 | 3.50 | 37.86 | 21.53 | 0.8628 | 1.74 | 6.14 | 501,518.50 | 7.87 | 7.14 | 9.75 | 8.51 | 71.63 | 68.72 | 9.13 | 10.06 | 2.15 | 46.91 | 0.3852 | 0.00 | 30.73 | 24.53 | -40.93 | 105.15 | 5.67 | -- |
| West Pharmaceutical Services Inc | 3.07bn | 493.70m | 18.10bn | 10.80k | 36.98 | 5.70 | 27.81 | 5.89 | 6.79 | 6.79 | 42.28 | 44.11 | 0.7769 | 4.80 | 5.40 | 284,638.90 | 12.11 | 15.24 | 14.29 | 18.19 | 35.91 | 37.89 | 15.59 | 18.67 | 2.34 | -- | 0.0614 | 10.13 | 6.25 | 7.44 | 0.203 | 7.36 | 10.39 | 5.51 |
| Zimmer Biomet Holdings Inc | 8.23bn | 704.60m | 19.47bn | 17.00k | 28.06 | 1.53 | 10.82 | 2.36 | 3.55 | 3.55 | 41.44 | 64.95 | 0.3703 | 1.10 | 5.17 | 484,211.80 | 3.17 | 3.03 | 3.58 | 3.46 | 69.71 | 71.01 | 8.56 | 9.10 | 1.10 | 4.71 | 0.3718 | 29.26 | 7.20 | 6.08 | -21.98 | -- | 9.26 | 0.00 |
| Illumina Inc | 4.34bn | 850.00m | 20.32bn | 8.60k | 24.26 | 7.47 | 18.14 | 4.68 | 5.48 | 5.48 | 27.88 | 17.80 | 0.6709 | 2.61 | 5.34 | 505,000.00 | 13.13 | -10.15 | 17.32 | -12.15 | 66.61 | 65.39 | 19.57 | -23.18 | 1.72 | 15.79 | 0.4221 | -- | -0.6633 | 6.04 | 169.50 | 5.32 | -4.77 | -- |
| Steris PLC | 5.83bn | 708.66m | 24.30bn | 17.79k | 34.48 | 3.40 | 20.30 | 4.17 | 7.19 | 7.18 | 59.09 | 72.93 | 0.5658 | 4.92 | 6.12 | 327,662.40 | 6.91 | 5.04 | 7.59 | 5.51 | 44.11 | 43.75 | 12.21 | 10.69 | 1.75 | 20.99 | 0.2094 | 37.51 | 6.24 | 12.49 | 10.64 | 8.40 | 11.52 | 8.99 |
| DexCom Inc | 4.66bn | 836.30m | 28.40bn | 11.00k | 35.71 | 10.34 | 26.10 | 6.09 | 2.07 | 2.07 | 11.50 | 7.14 | 0.727 | 3.02 | 4.20 | 423,818.20 | 13.04 | 8.85 | 21.58 | 12.58 | 62.09 | 63.92 | 17.94 | 14.21 | 1.59 | -- | 0.3204 | -- | 15.60 | 19.33 | 45.14 | 8.75 | 12.81 | -- |
Data as of Mar 03 2026. Currency figures normalised to Zimmer Biomet Holdings Inc's reporting currency: US Dollar USD
56.38%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dodge & Coxas of 31 Dec 2025 | 23.51m | 11.86% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 21.51m | 10.85% |
| T. Rowe Price Associates, Inc. (IM)as of 31 Dec 2025 | 13.34m | 6.73% |
| Harris Associates LPas of 31 Dec 2025 | 12.26m | 6.19% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 11.02m | 5.56% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 8.83m | 4.45% |
| Capital Research & Management Co. (International Investors)as of 31 Dec 2025 | 7.13m | 3.60% |
| Geode Capital Management LLCas of 31 Dec 2025 | 5.23m | 2.64% |
| American Century Investment Management, Inc.as of 31 Dec 2025 | 4.92m | 2.48% |
| PRIMECAP Management Co.as of 31 Dec 2025 | 4.00m | 2.02% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
